Rantac (Ranitidine)Usage,Side Effects and Dosage

Manufacturer of Rantac Tablet

 Rantac Tablet is manufactured by J.B.Chemicals & Pharmaceuticals Ltd (JBCPL) established in 1976.JBCPL is one of India’s fastest growing pharmaceutical companies and exports drugs to over 30 countries across the world .JBCPL has its headquarters in India’s financial capital, Mumbai.

                                                         

 Content of Rantac Tablet

Rantac tablet contains Ranitidine .It is a histamine H2-receptor antagonist that inhibits stomach acid production.

Usage of Rantac Tablet
 Rantac tablet is used for the treatment of,

• Stomach and intestines ulcers. 
• Zollinger-Ellison syndrome and  erosive esophagitis(stomach and throat (esophagus) problems caused by too much stomach acid secretions) 
• Gastroesophageal reflux disease-GERD(a backward flow of stomach acid into the esophagus)  
• Skin disease such as hives. 
• Used to relieve stomach irritation and ulceration caused by certain painkillers such as non-steroidal anti-inflammatory drugs (NSAIDs).

Side Effects of Rantac Tablet
 Common side effects are,

•  Headache, constipation, diarrhoea, nausea or vomiting, stomach pain. dizziness.

• Minor increases in serum transaminases, which may be important in patients with liver disease.

Contact your doctor if any of the following symptoms occur,

•  Hypersensitivity reactions included rash, urticaria, bronchospasm, fever, eosinophilia, angioneurotic edema, acute eosinophilic pneumonia and anaphylaxis.

Dosage of Rantac Tablet

                                            

                                                    

• Adult Dose for Duodenal Ulcer: 150 mg 2 times a day, or 300 mg once a day after the evening meal or at bedtime.
•  Adult Dose for Erosive Esophagitis:Initial: 150 mg 4 times a day.Maintenance: 150 mg twice daily.
• Adult Dose for Zollinger-Ellison Syndrome: 150 mg 2 times a day initially. Adjust dose to control gastric acid secretion. Doses up to 6 g per day have been used.
•  Adult Dose for Pathological Hypersecretory Conditions: 150 mg 2 times a day initially. 
• Adult Dose for Gastroesophageal Reflux Disease: 150 mg twice daily. 
• Adult Dose for Gastric Ulcer: 150 mg twice a day.

FDA pregnancy of Rantac Tablet

 Rantac tablet falls under the category B of US FDA. Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Ranitidine is known to cross the placenta.